Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation

Philip R. Krause; Narendra Arora; William Dowling; César Muñoz-Fontela; Simon Funnell; Rogerio Gaspar; Marion F. Gruber; Adam Hacker; Ana Maria Henao-Restrepo; Stanley Plotkin; Helen V. Rees; Dean K. Smith; Soumya Swaminathan

doi:10.1016/j.vaccine.2022.07.028

Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation

Philip R. Krause
, Narendra Arora
, William Dowling
, César Muñoz-Fontela
, Simon Funnell
, Rogerio Gaspar
, Marion F. Gruber
, Adam Hacker
, Ana Maria Henao-Restrepo
, Stanley Plotkin
, Helen V. Rees
, Dean K. Smith
, Soumya Swaminathan

Research output: Contribution to journal › Comment/debate

7 Scopus citations

Original language	English
Pages (from-to)	5749-5751
Number of pages	3
Journal	Vaccine
Volume	40
Issue number	40
DOIs	https://doi.org/10.1016/j.vaccine.2022.07.028
State	Published - 22 Sep 2022
Externally published	Yes

Access to Document

10.1016/j.vaccine.2022.07.028

Cite this

Krause, P. R., Arora, N., Dowling, W., Muñoz-Fontela, C., Funnell, S., Gaspar, R., Gruber, M. F., Hacker, A., Henao-Restrepo, A. M., Plotkin, S., Rees, H. V., Smith, D. K., & Swaminathan, S. (2022). Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation. Vaccine, 40(40), 5749-5751. https://doi.org/10.1016/j.vaccine.2022.07.028

@article{3be9bc78f8bf4772b5326fc56e4d3150,

title = "Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation",

author = "Krause, \{Philip R.\} and Narendra Arora and William Dowling and C{\'e}sar Mu{\~n}oz-Fontela and Simon Funnell and Rogerio Gaspar and Gruber, \{Marion F.\} and Adam Hacker and Henao-Restrepo, \{Ana Maria\} and Stanley Plotkin and Rees, \{Helen V.\} and Smith, \{Dean K.\} and Soumya Swaminathan",

note = "Funding Information: We gratefully acknowledge the worldwide scientific community for their contributions to discussions at WHO-sponsored meetings at which this framework was discussed. We also gratefully acknowledge Marco Cavaleri for helpful comments on this manuscript. The opinions in this manuscript do not necessarily reflect those of the authors{\textquoteright} institutions.",

year = "2022",

month = sep,

day = "22",

doi = "10.1016/j.vaccine.2022.07.028",

language = "English",

volume = "40",

pages = "5749--5751",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Ltd.",

number = "40",

}

Krause, PR, Arora, N, Dowling, W, Muñoz-Fontela, C, Funnell, S, Gaspar, R, Gruber, MF, Hacker, A, Henao-Restrepo, AM, Plotkin, S, Rees, HV, Smith, DK & Swaminathan, S 2022, 'Making more COVID-19 vaccines available to address global needs: Considerations and a framework for their evaluation', Vaccine, vol. 40, no. 40, pp. 5749-5751. https://doi.org/10.1016/j.vaccine.2022.07.028

TY - JOUR

T1 - Making more COVID-19 vaccines available to address global needs

T2 - Considerations and a framework for their evaluation

AU - Krause, Philip R.

AU - Arora, Narendra

AU - Dowling, William

AU - Muñoz-Fontela, César

AU - Funnell, Simon

AU - Gaspar, Rogerio

AU - Gruber, Marion F.

AU - Hacker, Adam

AU - Henao-Restrepo, Ana Maria

AU - Plotkin, Stanley

AU - Rees, Helen V.

AU - Smith, Dean K.

AU - Swaminathan, Soumya

N1 - Funding Information: We gratefully acknowledge the worldwide scientific community for their contributions to discussions at WHO-sponsored meetings at which this framework was discussed. We also gratefully acknowledge Marco Cavaleri for helpful comments on this manuscript. The opinions in this manuscript do not necessarily reflect those of the authors’ institutions.

PY - 2022/9/22

Y1 - 2022/9/22

UR - https://www.scopus.com/pages/publications/85135524293

U2 - 10.1016/j.vaccine.2022.07.028

DO - 10.1016/j.vaccine.2022.07.028

M3 - Comment/debate

C2 - 35941036

AN - SCOPUS:85135524293

SN - 0264-410X

VL - 40

SP - 5749

EP - 5751

JO - Vaccine

JF - Vaccine

IS - 40

ER -